Search

BICALUTAMIDE GT 150 MG, Comprimé pelliculé (Retiré du marché)

Details

--- Description
Pack Boîte de 20
Strength (Dosage)
Laboratory ATLAS PHARM
Ingredients Bicalutamide
Therapeutic class Antinéoplasique, antiandrogène
ATC code L02BB03
PPH $86.90
PPV $114.40
Refundable Yes
Refund base $118.80
Refund rate $0.00
Table A
Marketing status Commercialized
Type Medication
Uses Cancer de la prostate métastasé
Cancer de la prostate métastasé, en association à une castration médicale ou chirurgicale.
Cancer de la prostate localement avancé
Bicalutamide est indiqué chez les patients atteints d’un cancer de la prostate localement avancé, à haut risque de progression de la maladie, soit en traitement seul soit en traitement adjuvant à la prostatectomie radicale ou à la radiothérapie.
Warnings
Dosage
Avoid
Side effects
Interactions

Medications with one or more of the ingredients above


Medications under one or more of the therapeutic classes above


Medications from the same laboratory


Disclaimer
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.